Diisopropylethylamine → (S)-2-[4-(2-fluoro-3-hydroxy-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-4-methyl-pentanoic acid [1-(2-hydroxy-2-methyl-propyl)-1H-pyrazol-3-yl]-amide

HRID 19135

Reaktionsgleichung

Reaktionsgleichung von HRID 19135
[F:1][C:2]1[C:22]([OH:23])=[CH:21][CH:20]=[CH:19][C:3]=1[O:4][C:5]1[CH2:9][N:8]([C@@H:10]([CH2:14][CH:15]([CH3:17])[CH3:16])[C:11]([OH:13])=O)[C:7](=[O:18])[CH:6]=1.Cl.[OH:25][C@@H:26]([CH2:56]O)[CH2:27][N:28]1[CH:32]=[CH:31][C:30]([NH:33]C(=O)[C@@H](N2CC(OC3C=CC=C(Cl)C=3Cl)=CC2=O)CC(C)C)=[N:29]1.F[P-](F)(F)(F)(F)F.N1(O[P+](N(C)C)(N(C)C)N(C)C)C2C=CC=C[C:68]=2N=N1.C(N(CC)C(C)C)(C)C>ClCCl>[OH:25][C:26]([CH3:56])([CH3:68])[CH2:27][N:28]1[CH:32]=[CH:31][C:30]([NH:33][C:11](=[O:13])[C@@H:10]([N:8]2[CH2:9][C:5]([O:4][C:3]3[CH:19]=[CH:20][CH:21]=[C:22]([OH:23])[C:2]=3[F:1])=[CH:6][C:7]2=[O:18])[CH2:14][CH:15]([CH3:17])[CH3:16])=[N:29]1

Komponenten

6

Edukt 4

HCID 81531DiisopropylethylamineHCID 151348Benzotriazol-1-yloxy-tris(dimethylamino)phosphonium hexafluorophosphateHCID 66894967HCID 66894967, VerbindungHCID 66899094HMS5552 HCl

Produkt 1

HCID 44252755(S)-2-[4-(2-fluoro-3-hydroxy-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-4-methyl-pentanoic acid [1-(2-hydroxy-2-methyl-propyl)-1H-pyrazol-3-yl]-amideAusbeute 67,9 %

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 6344DichloromethaneLösungsmittel

Reaktionsbedingungen

Temperatur
0 °C

Versuchsvorschrift

To a solution of (S)-2-[4-(2-fluoro-3-hydroxy-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-4-methyl-pentanoic acid (0.100 g, 0.31 mmol) in dichloromethane (3 mL) was added 1-(3-amino-pyrazol-1-yl)-2-methyl-propan-2-ol (prepared in U.S. Pat. Appl. US2008021032 Example 80, 0.100 g, 0.64 mmol) and benzotriazol-1-yl-oxy-tris(dimethylamino)phosphonium hexafluorophosphate (0.137 g, 0.31 mmol). The mixture was stirred at 0° C. and N,N-diisopropylethylamine (0.04 g, 0.31 mmol) was added. The mixture was stirred at room temperature for 4 h and the solvents were evaporated. The residue was extracted with ethyl acetate and washed with a citric acid solution. The organic layer was washed with brine and dried over sodium sulfate. The solvents were evaporated and the residue was purified by reverse phase HPLC (C18, 20% to 100% acetonitrile/water) which afforded (S)-2-[4-(2-fluoro-3-hydroxy-phenoxy)-2-oxo-2,5-dihydro-pyrrol-1-yl]-4-methyl-pentanoic acid [1-(2-hydroxy-2-methyl-propyl)-1H-pyrazol-3-yl]-amide (0.097 g, 57%) as an off-white solid: HR-ES-MS m/z calculated for C23H29FN4O5 [M+H]+ 461.2195, observed 461.2194, 1H NMR (400 MHz, DMSO-d6) δ ppm 1.00 0.90 (d, J=6.4 Hz, 3H), 0.94 (d, J=6.4 Hz, 3H), 1.05 (s, 3H), 1.07 (s, 3H), 1.37-1.51 (m, 1H), 1.57 (ddd, J=13.6, 9.1, 4.8 Hz, 1H), 1.68-1.84 (m, 1H), 3.90 (s, 2H), 4.20 (d, J=18.5 Hz, 1H), 4.59 (d, J=18.5 Hz, 1H), 4.67 (s, 1H), 4.85-4.92 (m, 1H), 4.88 (s, 1H), 6.45 (d, J=1.9 Hz, 1H), 6.85 (t, J=7.4 Hz, 1H), 6.91 (t, J=7.9 Hz, 1H), 6.98-7.10 (m, 1H), 7.54 (d, J=1.9 Hz, 1H), 10.36 (br. s., 1H), 10.79 (s, 1H).

Aufarbeitung

  1. stirringThe mixture was stirred at room temperature for 4 h
  2. customthe solvents were evaporated
  3. extractionThe residue was extracted with ethyl acetate
  4. washwashed with a citric acid solution
  5. washThe organic layer was washed with brine
  6. dry with materialdried over sodium sulfate
  7. customThe solvents were evaporated
  8. customthe residue was purified by reverse phase HPLC (C18, 20% to 100% acetonitrile/water) which

Quellen und Nachweise

ORD-Eintrag
ord-0f6c8e1835264a3d93eb35bc68eba742
Quelldatensatz
uspto-grants-2010_06
Patentnummer
US07741327B2

Verknüpfte Notizen

Wird geladen…